Cellular Origins, a TTP Company, focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), has announced an international collaboration with Thermo Fisher Scientific.
Aragen, a contract research, development and manufacturing organisation (CRDMO), announced that it will commence GMP manufacturing at its biologics manufacturing facility in Bangalore, India from July 2025.
Shilpa Biocare, a fully-owned subsidiary of Shilpa Medicare, announces ahead of BIO Boston that it has secured a Europe-wide commercial supply agreement with Orion Corporation for Recombinant Human Albumin.
TekniPlex Healthcare, which utilises advanced materials science expertise to help deliver better patient outcomes, has commenced production activities at its new 200,000-square-foot facility in Madison, Wisconsin.
Oxford-based SynaptixBio, which is developing a therapy for a rare, deadly, and currently incurable rare disease (H-ABC), says it has identified the drug it will take forward into clinical trials.
Schneider Electric, a company in the digital transformation of energy management and automation, has announced new data centre solutions specifically engineered to meet the intensive demands of next-generation AI cluster architectures.
CluePoints, the sponsor of RBQMLive and provider of statistical and AI-driven software solutions, has announced the full agenda and expert speaker line up for the 4th annual RBQMLive.
Watson-Marlow Fluid Technology Solutions (WMFTS) has introduced WMArchitect Interchangeable Parts to secure a resilient supply of single-use assemblies by including pre-qualified, alternative components in the design stage.
Cherwell, an Analytichem company, cleanroom microbiology solutions company, has introduced a new range of plated prepared media designed to deliver sample security, data integrity, and optimised workflow in microbial monitoring.
XL-protein has announced that it has entered into a worldwide License, Development and Commercialisation Agreement with Grifols for a long-acting biopharmaceutical product.
Mark Wilkinson, technical director, Sanitas Healthcare discusses how in a significant move towards enhancing sustainability in healthcare, Sanitas Healthcare, recently launched the Protect Video Laryngoscope (VL).
